Eurax

New CEO for Medicines Australia

Autor Jenna

Dr Brendan Shaw has been appointed for example the fresh chief executive of Medicines Australia, its board announced today.

“After a thorough process the board and I are delighted to appoint Dr Shaw to this important condition within the discovery-based pharmaceutical effort; labors in Australia,” the chair of Medicines Australia, Will Delaat uttered.

“He brings a money of actual observation to navigate an ever-changing bio-pharmaceutical industry landscape and a challenging health and results policy environment.”

For the past six years Dr Shaw led the Health Policy and Research employment at Medicines Australia, representing the activity on the Pharmaceutical Benefits Pricing Authority, the Access to Medicines Working Group, and toward two years was the busy vigor member of the Economic Sub-Committee of the Pharmaceutical Benefits Advisory Committee. He has been acting master executive for the past three months.

“Brendan’s track memorial is impressive,” reported Mr Delaat. “He was instrumental in guiding the industry through reforms to the Pharmaceutical Benefits Scheme, the Pharmaceutical Benefits Advisory Committee processes and the Therapeutic Goods Administration. He has driven Medicines Australia’sitting careful search program, developed Joint Medicines Policy Conferences with the Australian Government, and Medicines Australia’s contribution to the between nations contention on health technology assessment.”